GOVMY is an Australian brand that focuses on cellular health, utilizing both intracellular and extracellular pathways to create global dual-pathway anti-aging products. Unlike the "one-size-fits-all" approach of many mainstream products, GOVMY continuously explores human anti-aging pathways and mechanisms. With a research-driven and targeted nutritional philosophy, the brand offers a range of gene-targeted products, including the dual-granule anti-aging series, chromosome whitening series, cellular slimming series, and basic nutritional supplements. This approach positions govmy as a global health and nutrition brand driven by cellular-level health research.

In 2009, nobel laureate dr. Elizabeth blackburn became the chief scientist of the GOVMY brand. She collaborated with the Australian cell anti-aging research center, the University of Sydney, the University of Queensland, and the University of New South Wales to establish the Australian regenerative medicine laboratory. After a decade of research and over 3,000 experiments, dr. Blackburn and her team discovered the revolutionary "recombinant aggregated signaling peptides" technology. This innovation made GOVMY the world's first brand to introduce dual-pathway anti-aging at the cellular level.